At the request of the Government of Canada, CRISM is rapidly developing a series of six national guidance documents that collectively address urgent needs of people who use substances, service providers, and decision makers, in relation to the COVID‑19 pandemic. The guidance provided in these documents is subject to change as new information becomes available and the landscape of the pandemic and public health responses evolve over time.
CRISM welcomes feedback on these documents. We invite interested readers to share their comments and feedback using this brief online survey mechanism. Please provide source references to support your recommendations for changes, as appropriate. All information you provide will remain anonymous; however we ask you to provide some information to help us document the diversity of feedback received from stakeholders.